PTC Therapeutics (NASDAQ:PTCT) Cut to Sell at Citigroup
Citigroup downgraded shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) from a neutral rating to a sell rating in a research note issued to investors on Friday morning, MarketBeat Ratings reports. Citigroup currently has $17.00 target price on the biopharmaceutical company’s stock, down from their previous target price of $29.00. Several other equities analysts have […]
More Stories
iShares MSCI Qatar ETF (NASDAQ:QAT) Short Interest Up 759.7% in September
iShares MSCI Qatar ETF (NASDAQ:QAT – Get Free Report) saw a significant increase in short interest in September. As of...
Short Interest in Virtus Equity & Convertible Income Fund (NYSE:NIE) Rises By 643.1%
Virtus Equity & Convertible Income Fund (NYSE:NIE – Get Free Report) was the target of a significant increase in short...
Short Interest in The New America High Income Fund Inc. (NYSE:HYB) Decreases By 78.0%
The New America High Income Fund Inc. (NYSE:HYB – Get Free Report) was the target of a large decline in...
Innergex Renewable Energy (OTCMKTS:INGXF) Share Price Passes Above 50-Day Moving Average – What’s Next?
Innergex Renewable Energy Inc. (OTCMKTS:INGXF – Get Free Report) shares passed above its fifty day moving average during trading on...
SmartCentres Real Estate Investment Trst (TSE:SRU.UN) Shares Cross Above 50-Day Moving Average – Here’s What Happened
SmartCentres Real Estate Investment Trst (TSE:SRU.UN – Get Free Report) shares passed above its 50 day moving average during trading...
Hang Seng Bank (OTCMKTS:HSNGY) Stock Crosses Above 50-Day Moving Average – Here’s What Happened
Hang Seng Bank Limited (OTCMKTS:HSNGY – Get Free Report) passed above its fifty day moving average during trading on Tuesday...